566P A multicenter, open-label, dose-escalation, first-in-man study of MetAP2 inhibitor M8891 in patients with advanced solid tumoursM A Carducci,Ding Wang, C Habermehl, M Bödding, F Rohdich, S Stinchi, O Karpenko, C Gimmi,P LoRussoAnnals of Oncology（2020）引用 2|浏览15暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
